Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Emerging research on dual and triple agonists The success of GLP-1 agonists has led to research on new drugs that can target two or three points at the same time
Given that obesity and hypertension frequently coexist and together substantially increase cardiovascular and kidney risk, these findings support obesity treatment as an important component of blood pressure management and cardiovascular risk reduction, said lead researcher Marcel Muskiet, MD, PhD, an internist, endocrinologist, and vascular medicine specialist in the Department of Medicine at Leiden University Medical Center (LUMC) in the Netherlands
Another study done with mice by Forst and colleagues, showed that binding of GLP-1 to the GLP-1 receptor in the myocardium leads to an increase in production of cAMP and activation of protein kinase A, which yields an increase in glucose uptake and the inotropic effects of the heart
Injectable formulations like Ozempic, Trulicity, and Mounjaro are widely prescribed, with user-friendly pen devices enhancing patient compliance
BPC-157 and KPV are peptides often used to support healing, gut integrity, and inflammation balance
Adjust the application frequency and consult a dermatologist if needed
US$ 23.32
US$ 22.68
US$ 26.43
US$ 25.01
